BioForce Nanosciences Holdings Inc
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. The company offers private label products with distributors and manufacturing providers. It also sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, mass merchandisers, and online at www… Read more
BioForce Nanosciences Holdings Inc (BFNH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.051x
Based on the latest financial reports, BioForce Nanosciences Holdings Inc (BFNH) has a cash flow conversion efficiency ratio of 0.051x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-25.39K) by net assets ($-499.94K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
BioForce Nanosciences Holdings Inc - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how BioForce Nanosciences Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
BioForce Nanosciences Holdings Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioForce Nanosciences Holdings Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Park Street A/S
CO:PARKST-A
|
0.006x |
|
Afcon Holdings Ltd
TA:AFHL
|
0.022x |
|
Garibaldi Resources Corp
PINK:GGIFF
|
-0.015x |
|
Austral Gold Limited
PINK:AGLDF
|
0.377x |
|
Zenith Steel Pipes & Industries Limited
NSE:ZENITHSTL
|
-0.005x |
|
AcouSort AB
ST:ACOU
|
-0.260x |
|
Thai Wire Products Public Company Limited
BK:TWP
|
-0.050x |
|
Finlay Minerals Ltd
OTCQB:FYMNF
|
0.037x |
Annual Cash Flow Conversion Efficiency for BioForce Nanosciences Holdings Inc (2002–2024)
The table below shows the annual cash flow conversion efficiency of BioForce Nanosciences Holdings Inc from 2002 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-2.30 Million | $-61.25K | 0.027x | +3.66% |
| 2023-12-31 | $-1.82 Million | $-46.70K | 0.026x | -49.43% |
| 2022-12-31 | $-1.35 Million | $-68.39K | 0.051x | -43.75% |
| 2021-12-31 | $-861.86K | $-77.77K | 0.090x | -59.50% |
| 2020-12-31 | $-359.91K | $-80.20K | 0.223x | +143.23% |
| 2019-12-31 | $47.31K | $-24.38K | -0.515x | +75.41% |
| 2018-12-31 | $29.80K | $-62.47K | -2.096x | +33.62% |
| 2017-12-31 | $8.20K | $-25.90K | -3.158x | -512.28% |
| 2016-12-31 | $2.29K | $1.75K | 0.766x | +1409208.02% |
| 2015-12-31 | $17.11K | $-0.93 | 0.000x | -100.01% |
| 2013-12-31 | $21.91K | $22.16K | 1.011x | +182.18% |
| 2008-12-31 | $2.23 Million | $-2.75 Million | -1.231x | 0.00% |
| 2007-12-31 | $2.23 Million | $-2.75 Million | -1.231x | -82.72% |
| 2006-12-31 | $3.94 Million | $-2.66 Million | -0.674x | +96.12% |
| 2005-12-31 | $91.43K | $-1.59 Million | -17.377x | -496.82% |
| 2004-12-31 | $437.88K | $-1.27 Million | -2.912x | +40.82% |
| 2003-12-31 | $246.65K | $-1.21 Million | -4.919x | -637.62% |
| 2002-12-31 | $1.44 Million | $-960.25K | -0.667x | -- |